HCW Biologics Inc. (HCWB)
1.17
+0.05
(+4.46%)
USD |
NASDAQ |
Oct 23, 16:00
1.14
-0.03
(-2.56%)
After-Hours: 20:00
HCW Biologics Price : 1.17 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.12 | 1.191 | 1.09 | 1.17 | 80635.00 |
| Oct 22, 2026 | 1.15 | 1.15 | 1.10 | 1.12 | 49323.00 |
| Oct 21, 2026 | 1.17 | 1.21 | 1.15 | 1.16 | 50068.00 |
| Oct 20, 2026 | 1.25 | 1.27 | 1.17 | 1.17 | 98377.00 |
| Oct 19, 2026 | 1.24 | 1.34 | 1.23 | 1.23 | 99113.00 |
| Oct 16, 2026 | 1.23 | 1.27 | 1.22 | 1.24 | 78765.00 |
| Oct 15, 2026 | 1.17 | 1.280 | 1.15 | 1.23 | 48606.00 |
| Oct 14, 2026 | 1.241 | 1.26 | 1.14 | 1.17 | 59858.00 |
| Oct 13, 2026 | 1.30 | 1.45 | 1.25 | 1.26 | 2.136M |
| Oct 12, 2026 | 1.56 | 1.60 | 1.47 | 1.48 | 42977.00 |
| Oct 09, 2026 | 1.60 | 1.728 | 1.52 | 1.60 | 79975.00 |
| Oct 08, 2026 | 1.59 | 1.61 | 1.51 | 1.53 | 46376.00 |
| Oct 07, 2026 | 1.55 | 1.62 | 1.54 | 1.56 | 30681.00 |
| Oct 06, 2026 | 1.61 | 1.63 | 1.55 | 1.57 | 37825.00 |
| Oct 05, 2026 | 1.64 | 1.69 | 1.55 | 1.64 | 83290.00 |
| Oct 02, 2026 | 1.66 | 1.721 | 1.65 | 1.68 | 66529.00 |
| Oct 01, 2026 | 1.747 | 1.747 | 1.671 | 1.69 | 55702.00 |
| Sep 30, 2026 | 1.77 | 1.823 | 1.71 | 1.71 | 48410.00 |
| Sep 29, 2026 | 1.81 | 1.85 | 1.75 | 1.75 | 52063.00 |
| Sep 28, 2026 | 1.86 | 1.895 | 1.71 | 1.82 | 104526.0 |
| Sep 25, 2026 | 1.88 | 2.00 | 1.81 | 1.93 | 418789.0 |
| Sep 24, 2026 | 1.69 | 3.12 | 1.67 | 1.99 | 13.67M |
| Sep 23, 2026 | 1.81 | 1.83 | 1.610 | 1.66 | 161354.0 |
| Sep 22, 2026 | 1.91 | 1.98 | 1.70 | 1.81 | 133709.0 |
| Sep 21, 2026 | 1.95 | 2.02 | 1.87 | 1.91 | 59231.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 58.02 |
| Oncolytics Biotech, Inc. | 0.5023 |
| Sangamo Therapeutics, Inc. | 0.115 |
| Sarepta Therapeutics, Inc. | 17.73 |
| Anixa Biosciences, Inc. | 2.99 |
Price Related Metrics
| PS Ratio | 0.1381 |
| Price to Book Value | 0.2548 |
| Earnings Yield | -2.43K% |
| Market Cap | 1.893M |